Orphazyme A/S - ADR
The momentum for this stock is not very good. Orphazyme A/S - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Orphazyme A/S - ADR.
Log in to see more information.
News
Pomerantz LLP Announces Notice of Pendency and Proposed Settlement For All Persons Who Purchased, or Otherwise Acquired, The American Depositary Shares of Orphazyme A/S in its September 2020
PR Newswire Pomerantz LLP Announces Notice of Pendency and Proposed Settlement For All Persons Who Purchased, or Otherwise Acquired, The American Depositary Shares of Orphazyme A/S in its September 2020 Initial...\n more…